Publikationen in Zusammenarbeit mit Forschern von French Institute of Health and Medical Research (11)

2020

  1. 2018 updated European League against Rheumatism evidence-based recommendations for the diagnosis of gout

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 1, pp. 31-38

  2. High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?

    Rheumatology and Therapy, Vol. 7, Núm. 4, pp. 1011-1019

2019

  1. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

    RMD Open, Vol. 5, Núm. 2

  2. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600

2015

  1. 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Arthritis and Rheumatology, Vol. 67, Núm. 10, pp. 2557-2568

  2. 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1789-1798

2012

  1. Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2129-2143

  2. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2009

  1. Gout Study Group: Update on hyperuricemia and gout

    Joint Bone Spine

2007

  1. Lowering serum uric acid levels: What is the optimal target for improving clinical outcomes in gout?

    Arthritis Care and Research, Vol. 57, Núm. 7, pp. 1324-1328